The two antibody results answer different questions. One asks whether the body has ever met this virus. The other asks whether it is meeting it right now. Almost every confusing hepatitis A report comes from mixing those two questions up.
Hepatitis A is an infection of the liver caused by the hepatitis A virus, spread mainly by the fecal to oral route through contaminated food or water and through close personal contact 1. It is the only common viral hepatitis that does not establish a long term infection in the liver, and a critical review of viral hepatitis describes it as an acute, self limiting illness rather than a chronic one 2.
A blood test matters for two separate reasons. The first is that acute liver inflammation looks much the same from the outside no matter what caused it. Fatigue, nausea, dark urine, pale stools and yellowing of the eyes can come from a virus, from some medicines (ask your prescriber), from alcohol or from several other causes. Serology narrows that list quickly.
The second reason has nothing to do with being unwell. Antibody status tells you whether the immune system already recognises this virus. Many adults carry that antibody without ever recalling an illness, because the infection is frequently silent in childhood and far more likely to produce obvious symptoms and jaundice in adults 3. Knowing your status before an exposure is useful information. Finding it out afterwards is reassurance that arrives late.
So one test name covers two very different conversations, one about a current illness and one about long term protection. Which conversation you are in depends entirely on which antibody is reactive.
The test looks for antibodies the immune system makes against the hepatitis A virus, not for the virus itself. A laboratory immunoassay detects those antibodies in a serum sample from a standard blood draw and reports them as reactive or non-reactive, sometimes with a numeric index value next to the result.
Two forms are commonly ordered. Anti-HAV IgM detects only the early antibody class. Anti-HAV total detects IgM and IgG together in a single result, which is why a total result on its own cannot say whether the antibody is new or decades old. Some laboratories also offer an IgG only assay, which answers the immunity question without the noise of a recent response.
For a person sitting in a clinic with symptoms or a question about immunity, the antibody tests do the work.
One more thing the test does not do. It does not measure how sick the liver is. That is what the liver enzyme panel is for, and the two are read together rather than one standing in for the other.
IgM is the antibody class the immune system produces first, and studies indicate it is usually detectable around the time symptoms begin and then fades over the months that follow 4. Its presence is a time stamp. It says the immune system is responding to this virus now or responded to it recently.
IgG is the antibody class that replaces IgM and stays. Research suggests that antibody persisting after a resolved hepatitis A infection provides long lasting protection against getting the infection again 3. Vaccination produces antibody of the same class, which is why serology alone cannot always separate the two histories.
Total antibody is simply both classes measured together. Because IgG usually outnumbers and outlasts IgM, a reactive total result most often reflects IgG. But a person in the middle of an acute infection will also have a reactive total result, since IgM counts toward the total. That overlap is the single most common source of confusion in hepatitis A reports.
The practical rule is short. Total answers ever. IgM answers now. Order total when the question is immunity. Order IgM, or both, when the question is a current illness or a recent exposure. A clinician decides which combination fits the situation in front of them.
The two results are read as a pair, and the pattern they form carries more meaning than either line alone. The table below sets out the combinations a laboratory report can show and what each pattern usually reflects.
| Total antibody (anti-HAV total) | IgM antibody (anti-HAV IgM) | What the pattern usually reflects |
|---|---|---|
| Non-reactive | Non-reactive | No detectable antibody. Usually read as no sign of past infection and no measurable vaccine response. |
| Reactive | Reactive | A recent or current infection. Read alongside symptoms, exposure history and liver enzymes. |
| Reactive | Non-reactive | Past infection or antibody from vaccination. Usually read as immunity, with no sign of a recent infection. |
| Non-reactive | Reactive | An unusual combination, since total includes IgM. Normally repeated and reviewed with a clinician before anything is concluded. |
None of these patterns is a diagnosis by itself. Each is an observation that gains meaning from timing, exposure and how the person feels. A reactive IgM in someone with jaundice and a recent exposure means something quite different from the same result in someone with no symptoms who was screened for an unrelated reason.
If your report shows only one of the two lines, that is normal. Many clinicians order the one test that answers their question rather than both, and the missing line can be added later from a fresh sample.
A reactive, or positive, total hepatitis A antibody result means antibody to the virus is detectable in your blood. In the great majority of cases, that is a statement about the past rather than the present.
There are three explanations. The first is a resolved infection, sometimes one you never noticed, since the illness is often silent in childhood and far more symptomatic in adults 3. The second is vaccination, which produces detectable antibody against the same virus 5. The third, far less common, is an infection happening now, in which case IgM is normally reactive too and liver enzymes are usually elevated.
What the result does not tell you is when. A total antibody result carries no date. It cannot separate an infection from twenty years ago from a vaccine response, and it cannot say how strong that protection is in any individual.
For most people, the practical meaning of a reactive total with a non-reactive IgM is straightforward. The immune system recognises this virus. Whether anything further is needed, including whether vaccination still has a role, is a judgement for a licensed provider who can see your history. The result itself is a fact about your immune memory, not an instruction.
A positive IgM result points to a recent or current hepatitis A infection, and it is the result that changes what happens next. Studies indicate that IgM becomes detectable around the onset of illness and then declines over the following months, which is why it is the marker used to identify an acute case 4.
It is still an observation rather than a conclusion. A clinician reads it against symptoms, exposure history, liver enzymes and timing. In someone with jaundice, nausea and a plausible exposure, a reactive IgM fits an acute infection well.
Acute hepatitis A is also a reportable condition in most public health systems, so a laboratory confirmed result often triggers contact from a public health team. That is routine, and it exists because the virus spreads person to person.
A reactive IgM is worth discussing with a clinician promptly rather than waiting for the next scheduled appointment, especially alongside jaundice or persistent vomiting. Never set an abnormal result aside because you feel reasonably well.
A non-reactive, or negative, result means no antibody was detected at the level the assay can measure. For a total antibody test, that is usually read as no sign of past infection and no measurable response to vaccination, which means the immune system has no recorded memory of this virus.
There are a few situations where a non-reactive result is less final than it looks. Very early in an infection, antibody may not have risen yet, so a sample drawn in the first days after an exposure can be non-reactive while the infection is still developing. In people with a weakened immune system, antibody responses can be blunted, so a non-reactive result does not always mean no exposure ever occurred. And antibody levels after vaccination can fall below an assay cut-off in some people while immune memory remains, which is one reason serology is not a universal way to check vaccine status.
The practical next step depends on why the test was ordered. For someone checking immunity, a non-reactive result is the start of a conversation with a licensed provider about whether vaccination is appropriate. For someone recently exposed, it may mean repeating the test, and the timing of any repeat is a clinical decision rather than a fixed rule you can apply yourself.
Timing changes everything, because antibody tests measure a response that takes time to appear. The incubation period for hepatitis A runs for several weeks between exposure and the start of symptoms, and the virus is shed in stool at high levels before a person feels unwell 3. That gap is why a test drawn immediately after a suspected exposure often shows nothing useful.
Outbreak investigations lean on the same biology. Detection work in developed countries has to account for transmission that happens before cases are recognised, which is part of why control measures focus on contacts rather than only on people already diagnosed 7.
There is a second timing issue at the other end. IgM does not vanish the day you feel better. It can remain detectable for some months after recovery, so a reactive IgM in someone who was unwell a while ago may be a fading signal rather than a new event 4.
The useful habit is to write down dates. When was the suspected exposure, when did symptoms start, when was blood drawn. A result read without those dates is a line on a page. Read with them, it usually tells a coherent story. Decisions about when to test or retest belong to a clinician who has the full timeline.
Several ordinary situations produce results that look odd at first glance. The most common is a reactive total antibody in someone with no memory of ever being ill, which is explained by how often the infection passes unnoticed, particularly when it is acquired young 3.
A second is a reactive IgM that lingers after a resolved illness, which can look like a new infection on a report that carries no dates 4.
A third is a prolonged course. Hepatitis A usually resolves, but relapsing and cholestatic patterns are described, in which symptoms and laboratory abnormalities persist or return weeks after an apparent recovery 5. Someone in that situation can have liver enzymes that stay elevated long after they expected them to settle.
A fourth is an index value sitting close to the assay cut-off. Immunoassays are not binary machines, and a borderline value is a reason to repeat rather than to conclude. Assays also differ between laboratories, so results from two labs are not always directly comparable.
Finally, recent vaccination produces antibody that a total test will detect, which is only confusing if the vaccination is not in the record in front of the person reading the result. None of these patterns is a reason to dismiss a result. Each is a reason to interpret it with a clinician who can see the context.
People usually arrive at this test by one of four routes. The first is symptoms. Fatigue, loss of appetite, nausea, abdominal discomfort, dark urine and yellowing of the skin or eyes are the classic picture, and a closer look at hepatitis a symptoms shows how non-specific the early days can be. Serology is how that picture gets a name.
The second is a known or suspected exposure, through food, water or close contact with someone who has a confirmed infection. Here the IgM test and the timing of the draw matter most, and prompt contact with a clinician matters more than the test itself.
The third is an immunity question. Adults planning travel to areas where the virus is more common, people whose work brings them into contact with food preparation or sanitation, and people who simply want their status documented all ask the same question, and a total antibody or IgG test answers it.
The fourth is an unexplained liver enzyme elevation found on a routine panel. When enzymes are up and the cause is not obvious, viral serology is one of the first branches a clinician follows.
There is also a group where documented immunity carries extra weight. Severe outcomes from hepatitis A are associated with older age and with underlying chronic liver disease 5, so in people with existing liver conditions a provider may want immunity status on record.
The test is performed on a standard venous blood sample, usually a single tube drawn from the arm, and antibody testing does not require fasting. If hepatitis A serology is bundled into a wider panel, follow whatever preparation instructions come with that panel, since other markers in it may have their own requirements.
Results are reported in one of two formats. Most laboratories use qualitative wording, reactive or non-reactive, sometimes written as positive or negative. Others add a numeric index or signal to cut-off ratio, where a number above the stated threshold is reported as reactive. That number is not a measure of how protected or how unwell you are, and comparing index values between laboratories is not meaningful.
Turnaround depends on whether the assay runs in house or at a reference laboratory, so ask the ordering clinic rather than planning around a fixed number. If a result is urgent because of symptoms, say so when the sample is taken.
Testing of this kind sits inside broader panels as well. FitScript builds its membership around 150+ biomarkers tested per year, so markers of liver health are typically tracked over time rather than looked at once in isolation. Serology is a snapshot of immune history, and liver enzymes are the moving part worth watching across repeat draws.
Liver enzymes show how irritated the liver is right now, while antibodies show immune history. ALT sits inside liver cells and rises in the blood when those cells are injured, and research suggests the injury in hepatitis A is driven largely by the immune response to infected cells rather than by the virus damaging them directly 8.
Typical lab reference ranges run roughly 7 to 56 U/L for men and 7 to 33 U/L for women. FitScript's optimal range is narrower, 10 to 25 U/L for men and 8 to 19 U/L for women. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs, and reference ranges vary by laboratory, age and sex. The dedicated ALT guide covers how the marker is measured and what high or low values may reflect in far more detail.
Hepatitis A serology is rarely ordered alone, because the questions around it extend past one virus. A critical review of viral hepatitis sets out how differently these infections behave, with hepatitis A resolving while hepatitis B and C can persist in the liver 2.
| Feature | Hepatitis A | Hepatitis B | Hepatitis C |
|---|---|---|---|
| Usual route of spread | Fecal to oral, contaminated food or water, close contact | Blood and body fluids | Blood to blood |
| Can become a long term infection | No | Yes, in some people | Yes, commonly |
| Usual first blood tests | IgM and total antibody | A panel of antigen and antibody markers | Antibody screen, confirmed by a molecular test |
| Vaccine available | Yes | Yes | No |
Because each virus asks a different serological question, the panels differ. Understanding hepatitis b blood tests means learning to read surface antigen, surface antibody and core antibody as a set, while a hepatitis c test starts with an antibody screen that needs a molecular confirmation before anything is concluded. Completing the A, B and C set is how most people get a full picture rather than a partial one.
Alongside serology, a clinician may look at other liver markers, including AST, alkaline phosphatase, bilirubin, albumin and clotting measures, since those describe function and injury rather than exposure. Within a FitScript membership, Atlas, the AI health advisor, interprets those results together and flags patterns worth raising with a licensed provider.
After a laboratory confirmed acute infection, the expected path is recovery, because hepatitis A does not become a chronic liver infection the way hepatitis B and C can 2. Care is supportive and is directed by a clinician, who monitors symptoms and liver markers until they settle 6. Any treatment decisions belong to a licensed provider.
Recovery is not always quick or linear. Relapsing and prolonged cholestatic forms are described, where symptoms and abnormal laboratory values persist or return after an apparent improvement 5. A second wave of jaundice or fatigue weeks later is worth reporting rather than ignoring.
Severe illness is the exception rather than the rule, and it is associated with older age and with pre-existing chronic liver disease 5. In people with those risk factors, closer follow up is a reasonable clinical decision.
There is also a public health side. Because the virus spreads person to person and through contaminated food, a public health team may advise on hand hygiene, on contact follow up and on avoiding food preparation for others for a period. Follow their guidance rather than improvising.
Once the infection resolves, the antibody that remains reflects immune memory, and research suggests that memory provides long lasting protection against reinfection 3. A future total antibody test will stay reactive, which is expected and not a sign of ongoing illness.
Every hepatitis A result is worth discussing with a clinician or licensed provider, and some warrant a same-week conversation rather than a note for the next check-up. A reactive IgM, any degree of jaundice, dark urine with pale stools, persistent vomiting, severe abdominal pain, or confusion and unusual drowsiness are all worth discussing with a clinician promptly.
So is a liver enzyme pattern that does not settle in the expected direction over repeat draws, or a result that conflicts with how you feel. A non-reactive total antibody result is less urgent but still useful to raise, because it opens a conversation about whether vaccination is appropriate for you, which a licensed provider decides after reviewing your history.
Bring three things to that conversation. The dates, including exposure, symptom onset and blood draw. The full report, including index values and the reference ranges printed on it. And your history, including any previous vaccination, past liver results and any medicines you take, which you should raise with your prescriber rather than changing yourself.
This article is educational and is not medical advice. A single antibody line does not define your liver health, and no result on a page replaces a clinician who can see the whole picture.
It means antibody to the hepatitis A virus was detected in your blood. Most often that reflects a past infection your body cleared or antibody produced after vaccination, and it is usually read as immunity. The total result carries no date, so it cannot say when the antibody appeared. Your clinician reads it alongside your history and, if relevant, an IgM result.
Usually not. Total antibody includes the long lasting class that persists for years, so a reactive result on its own points to the past far more often than the present. A current infection normally also shows a reactive IgM and raised liver enzymes. If you have symptoms, ask your clinician whether an IgM test should be added.
IgM is the antibody class that appears early, so a positive result points to a recent or current infection. It is an observation rather than a diagnosis, and it is interpreted with your symptoms, exposure history, timing and liver enzymes. A positive IgM is worth discussing with a clinician promptly, especially alongside jaundice or persistent vomiting.
Not reliably on its own. Vaccination and a resolved infection both produce the same antibody class, so a total or IgG result can look identical either way. Your vaccination record is what usually separates the two. A licensed provider decides whether that distinction changes anything for you.
No, antibody testing does not require fasting. If the test is bundled into a wider panel, follow the preparation instructions that come with that panel, because other markers in it may have their own requirements. Check with the ordering clinic if you are unsure.
Not immediately. Antibody takes time to rise, so a sample drawn in the first days after a suspected exposure can be non-reactive even when an infection is developing. Note the date of the exposure and tell your clinician, who decides when testing or repeat testing makes sense.
It means no antibody was detected at the level the assay measures, which is usually read as no sign of past infection and no measurable vaccine response. Very early infection and a weakened immune response are two reasons a negative result may not be final. Discuss with a licensed provider whether vaccination is appropriate for you.
They are often ordered together, because each virus answers a different question and uses a different panel. Hepatitis A serology shows exposure and immunity, while hepatitis B and C testing looks for infections that can persist. Your clinician decides which combination fits your history and symptoms.